Advertisement
Screener

TriSalus Life Sciences, Inc. (TLSI) Net Margin

TriSalus Life Sciences, Inc. (TLSI) Net Margin

  • 2026-06-30: Net Margin -80.54%.
  • 2026-03-31: Net Margin 17.29%.
  • 2025-12-31: Net Margin -73.86%.
  • 2025-09-30: Net Margin -93.47%.

Complete source-backed net margin history.

Available history
2022-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-80.54%
2026-03-3117.29%
2025-12-31-73.86%
2025-09-30-93.47%
2025-06-30-73.91%
2025-03-31-113.18%
2024-12-31-122.36%
2024-09-30-32.64%
2024-06-30-58.83%
2024-03-31-204.52%
2023-12-31-622.95%
2023-09-30-27.44%
2023-06-30-303.23%
2023-03-31-278.59%
2022-12-31-698.76%
2022-09-30-206.30%

Annual Net Margin

DateNet Margin
2025-12-31-86.88%
2024-12-31-102.09%
2023-12-31-320.69%
2022-12-31-380.60%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cytosorbents Corp (CTSO)United States$0.274B-1.29
Mobia Medical, Inc. (MOBI)United States$0.293B
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Embecta Corp. (EMBC)United States$0.319B2.10
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Neuronetics, Inc. (STIM)United States$0.216B-3.25